No therapeutic, physiological, performance-related, cosmetic, nutritional, or veterinary claims are made or implied
Polysaccharide peptides from Ganoderma lucidum ameliorate lipid metabolic disorders and gut microbiota dysbiosis in high-fat diet-fed rats
However, we will delay enforcement of these finalized policies until April 1, 2026
Its a type of medication used to treat obesity and type 2 diabetes mellitus (T2DM)
Available in injectable, and intravenous forms for flexibility in administration
When to Adjust Dosing Increase dose if: After 4-6 weeks at current dose, no measurable body composition changes occur, youre tolerating current dose without side effects, youre below the upper clinical range (1 mg daily), and your physician approves escalation based on comprehensive assessment